Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARQ 197 in MiT Tumors
NCT00557609Phase 2Completed
- Start
- Oct 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tivantinib in clear cell sarcoma (CCS), alveolar soft part sarcoma (ASPS), Renal cell carcinoma, translocation-associated (tRCC). Started Oct 2007; status: completed.
02
Drugs
tivantinib
03
Conditions
clear cell sarcoma (CCS)alveolar soft part sarcoma (ASPS)Renal cell carcinoma, translocation-associated (tRCC)
Beyond the preview
Go deeper on NCT00557609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557609.